Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Pablo Garcia-Pavia*, Claudio Rapezzi, Yehuda Adler, Michael Arad, Cristina Basso, Antonio Brucato, Ivana Burazor, Alida L. P. Caforio, Thibaud Damy, Urs Eriksson, Marianna Fontana, Julian D. Gillmore, Esther Gonzalez-Lopez, Martha Grogan, Stephane Heymans, Massimo Imazio, Ingrid Kindermann, Arnt V. Kristen, Mathew S. Maurer, Giampaolo MerliniAntonis Pantazis, Sabine Pankuweit, Angelos G. Rigopoulos, Ales Linhart

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)512-526
Number of pages15
JournalEuropean journal of heart failure
Volume23
Issue number4
DOIs
Publication statusPublished - Apr 2021

Keywords

  • TRANSTHYRETIN AMYLOIDOSIS
  • HEREDITARY
  • CARDIOMYOPATHY
  • MANAGEMENT
  • NOMENCLATURE
  • PREDICTORS

Cite this